cardiovascular diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Sub-study 1 & 4: 1. Men and women aged 20–74 years old. 2. No history of stroke or coronary heart disease 3. Signed informed consent. Sub-study 5: 1. Men and women aged 20–74 years old. 2. No history of stroke or coronary heart disease 3. Newly diagnosed hypertensive patients and is going to initiate antihypertensive drug treatment. 4. Signed informed consent.
Exclusion criteria
Exclusion criteria: Sub-study 1 & 5: 1. Patients with critical illness, such as malignant tumour or end-stage renal disease; 2. Patients with mental disease and cannot complete the examinations in the study; 3. Cannot bear the flashing light of fundus camera; 4. History of retinal laser therapy, cataract, blindness, or congenital miosis. Sub-study 4: 1. Patients with critical illness, such as malignant tumour or end-stage renal disease; 2. Patients with mental disease and cannot complete the examinations in the study; 3. Cannot bear the flashing light of fundus camera; 4. History of retinal laser therapy, cataract, blindness, or congenital miosis. 5. Cannot attending the three-day examinations.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ICC(same camera);C-index;correlation coefficient;ICC; | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean difference (same camera);coefficient of correlation (same camera);Mean difference (different camera);coefficient of correlation (different camera);ICC; | — |
Countries
China
Contacts
Peking University Clinical Research Institute